Read Ascent Peptides from the ground up.
Growth-hormone peptides can raise a signal; I’m interested in what that tells you about everyday life.
A message, a gland, then a blood result.
The growth hormone axis is the body’s message chain. The brain sends a hormone message to a small gland beneath it, the pituitary. That gland releases growth hormone.
Researchers often shorten that to GH. You’ll also meet IGF-1, a growth factor whose production GH helps drive.
The three peptides here copy that first message. They’re called secretagogues: substances that encourage a gland to release a hormone. They don’t supply GH itself. This review of the hormone family explains the connections if you want a closer look.
The message chain explains the family resemblance. Each molecule still gets its own page.
Three names, three different stories.
CJC-1295 caught researchers’ attention because one form kept hormone levels raised for days. Sermorelin has a childhood treatment history: a study found faster average growth in the first year among children diagnosed with a growth hormone shortage. That’s a reason to read further, with those children kept firmly in view.
Tesamorelin has approved medicines for adults who have HIV-associated lipodystrophy, a problem with fat distribution. Their use is to reduce excess abdominal fat. Its label says it isn’t indicated for weight loss. Sharing a hormone pathway doesn’t give all three the same evidence.
The comparison puts the people and results side by side.
Keep your own question in the picture.
Perhaps you arrived hoping to understand a claim about sleep, energy or body fat. Those are fair questions. A paper that reports higher hormone levels may leave them unanswered. I’m looking for a change the people could notice, beyond their blood results.
The same care matters with a prescription. A research finding can help frame a conversation, while a clinician needs the person’s history and the actual product. If you searched for Stafford growth hormone peptides, this site can explain the research; it can’t confirm a local provider or your eligibility.
The prescribing page explains what an individual review adds.
A rising signal is one part of the view.
A higher hormone level leaves a question open: did anything useful change for the people studied? The original papers and records help keep the answer tied to what was actually measured.